Alan Moore

Chief Strategy Officer

Alan Moore is Chief Strategy Officer at The Center for Breakthrough Medicines. Alan oversees new client development and on-boarding, building strategic partnerships and collaborations. He has 40 years of experience in the Life Sciences contract services field and most recently served as Vice President and Head of Strategic Alliances at WuXi Advanced Therapies. He was responsible for developing and maintaining strategic manufacturing relationships for autologous, allogeneic and gene-mediated cell and gene therapies, and strategic partnering in biologics services, Prior to that he served as Commercial Chief with primary responsibility for alignment of strategic partnering, business development efforts, and external collaborations. He oversaw the capital investment and capacity expansion for advanced therapies manufacturing at the Philadelphia Navy Yard campus. Prior to WuXi, he served as Executive VP and Chief Business Officer at Althea Technologies following his service at Genzyme where he held a Senior Regulatory Coordinator and VP of Biopharm Development Services position. His business unit manufactured early personalized therapies in conjunction with the NCI for phase III clinical trials of B cell lymphoma and multiple myeloma. Alan spent 16 years at Bioreliance moving from the lab to quality, and eventual management of the Biotech Services Division, and later serving as Director Business Development.